Shree Ganesh Remedies Ltd - 540737 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Susma Textiles Pvt Ltd & PACs Shree Ganesh Remedies Ltd - 540737 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Susma Textiles Pvt Ltd Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
We are pleased to announce that with the earnest efforts in Laboratory by doing all the Research & Development our Company "Shree Ganesh Remedies Limited" has achieved success in developing a new aromatic fine chemical product and had also received a trial export order from it''s International Client. The Company is expecting more export orders in coming financial year. Shree Ganesh Remedies Ltd - 540737 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the above subject matter we are submitting herewith the confirmation certificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent for the quarter ended on December 31,2019. Shree Ganesh Remedies Ltd - 540737 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ADITYA VIKRAMBHAI PATELDesignation :- Company Secretary and Compliance Officer Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Acquisition
Board Members in their meeting held on today i.e. 24th of December 2019, considered and approved to acquire, Ashok Pharma Chem, a partnership firm engaged in manufacturing of Pharmaceutical intermediate products. Shree Ganesh Remedies Ltd - 540737 - Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 30.09.2019.
Non-applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 for the half year ended 30.09.2019. Shree Ganesh Remedies Ltd - 540737 - Clarification For Unaudited Financial Results Submitted On November 14,2019 For The Half Year Ended On September 30, 2019.
In respect of our Unaudited Financial Results for the half year ended on September 30, 2019 filed on November 14, 2019 and pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"). We hereby inform you that the there was a clerical error with respect to the amount of the Finance Cost (actual amount of finance cost was mentioned instead of amount in Lacs) in the Profitability Statement which we have rectified in the attached document. Shree Ganesh Remedies Ltd - 540737 - Unaudited Financial Results Of The Company For The Half Year Ended On September 30, 2019.
The Board of Directors at the meeting held today i.e. November 14, 2019, inter alia, transacted following: - Approved Unaudited Financial Results of the Company for the half year ended on September 30, 2019 pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"). We enclose herewith: a) Unaudited Annual Financial Results (Standalone) for the Half Year ended September 30, 2019. b) Independent Auditors'' Limited Review Report on Unaudited Half Yearly Financial Results. Shree Ganesh Remedies Ltd - 540737 - Outcome Of Board Meeting Held On November 14, 2019.
The Board of Directors at the meeting held today i.e. November 14, 2019, inter alia, transacted following: - Approved Unaudited Financial Results of the Company for the half year ended on September 30, 2019 pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"). We enclose herewith: a) Unaudited Annual Financial Results (Standalone) for the Half Year ended September 30, 2019. b) Independent Auditors'' Limited Review Report on Unaudited Half Yearly Financial Results.